Anderson Woodrow D purchased $54K of INDV
Anderson Woodrow D (Chief Accounting Officer) purchased 1,500 shares of Indivior Pharmaceuticals, Inc. (INDV) at $35.69 on 2026-08-27.
How this was made
The 30-second read
Why it matters
The purchase modestly raises the insider's stake, but the amount is too small to drive price action.
Market read
Insider purchase of $53K is a low‑impact event for INDV.
What to watch
Potential upcoming regulatory or product milestones for INDV not disclosed in this filing.
Background
Form 4 filings disclose insider transactions; market participants monitor them for signals.
Ticker impact
Chief Accounting Officer purchased 1,500 shares for $53,535, increasing holdings to 27,638 shares.
Minimal short-term price movement expected.
The purchase size is modest relative to market cap and typical trading volume, reducing actionable significance.
Market effects
No broader sector impact; the transaction is company‑specific.
Limited to investors tracking INDV.
Negligible.
Counterpoint
The buy could be a routine portfolio adjustment rather than a confidence signal.
Key entities
- OfficerAnderson Woodrow D
Chief Accounting Officer of Indivior Pharmaceuticals, Inc.
